Mellors JW - Search Results

1

Future technologies for monitoring HIV drug resistance and cure.

Parikh UM, McCormick K, van Zyl G, Mellors JW. Parikh UM, et al. Among authors: mellors jw. Curr Opin HIV AIDS. 2017 Mar;12(2):182-189. doi: 10.1097/COH.0000000000000344. Curr Opin HIV AIDS. 2017. PMID: 28059958 Free PMC article. Review.

2

HIV-1 viral dynamics and viral load measurement: implications for therapy.

Riddler SA, Mellors JW. Riddler SA, et al. Among authors: mellors jw. AIDS Clin Rev. 1997-1998:47-65. AIDS Clin Rev. 1997. PMID: 9305443 Review. No abstract available.

3

Experts discuss findings on drug resistance.

Mellors J, Kemp S. Mellors J, et al. AIDS Alert. 2001 Aug;16(8):103-4. AIDS Alert. 2001. PMID: 11547700

4

In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase.

Parikh UM, Koontz DL, Chu CK, Schinazi RF, Mellors JW. Parikh UM, et al. Among authors: mellors jw. Antimicrob Agents Chemother. 2005 Mar;49(3):1139-44. doi: 10.1128/AAC.49.3.1139-1144.2005. Antimicrob Agents Chemother. 2005. PMID: 15728915 Free PMC article.

5

The 3'-azido group is not the primary determinant of 3'-azido-3'-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1.

Sluis-Cremer N, Arion D, Parikh U, Koontz D, Schinazi RF, Mellors JW, Parniak MA. Sluis-Cremer N, et al. Among authors: mellors jw. J Biol Chem. 2005 Aug 12;280(32):29047-52. doi: 10.1074/jbc.M503166200. Epub 2005 Jun 20. J Biol Chem. 2005. PMID: 15970587 Free article.

6

In vitro selection and analysis of human immunodeficiency virus type 1 resistant to derivatives of beta-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine.

Hammond JL, Parikh UM, Koontz DL, Schlueter-Wirtz S, Chu CK, Bazmi HZ, Schinazi RF, Mellors JW. Hammond JL, et al. Among authors: mellors jw. Antimicrob Agents Chemother. 2005 Sep;49(9):3930-2. doi: 10.1128/AAC.49.9.3930-3932.2005. Antimicrob Agents Chemother. 2005. PMID: 16127074 Free PMC article.

7

The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations.

Parikh UM, Bacheler L, Koontz D, Mellors JW. Parikh UM, et al. Among authors: mellors jw. J Virol. 2006 May;80(10):4971-7. doi: 10.1128/JVI.80.10.4971-4977.2006. J Virol. 2006. PMID: 16641288 Free PMC article.

8

Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level.

Parikh UM, Barnas DC, Faruki H, Mellors JW. Parikh UM, et al. Among authors: mellors jw. J Infect Dis. 2006 Sep 1;194(5):651-60. doi: 10.1086/505711. Epub 2006 Jul 24. J Infect Dis. 2006. PMID: 16897664

9

Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors.

Sluis-Cremer N, Sheen CW, Zelina S, Torres PS, Parikh UM, Mellors JW. Sluis-Cremer N, et al. Among authors: mellors jw. Antimicrob Agents Chemother. 2007 Jan;51(1):48-53. doi: 10.1128/AAC.00683-06. Epub 2006 Nov 6. Antimicrob Agents Chemother. 2007. PMID: 17088490 Free PMC article.

10

Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase.

Parikh UM, Zelina S, Sluis-Cremer N, Mellors JW. Parikh UM, et al. Among authors: mellors jw. AIDS. 2007 Jul 11;21(11):1405-14. doi: 10.1097/QAD.0b013e3281ac229b. AIDS. 2007. PMID: 17589186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

468 results

Search Page